Human study for the evaluation of the efficacy of aqueous extract of Acanthopanax on improving blood flow and blood pressure through the endothelium-dependent vasodilation

Dongguk University Ilsan Hospital0 个研究点目标入组 84 人开始时间: 待定最近更新: 2019年3月11日

试验速览

暂无简介。

•1) Subject who agrees to participate and signs informed consent form
•2) Age: 20~65 years
•3) Subject who has more than 2 risk factors of cardiovascular disease as follows: smoking, high blood pressure, high blood lipid level.

•1) Subject with high level of physical activity
•2) Woman who is postmenopausal or under hormone therapy.
•3) Subject whose body weight changes more than 10% within 8 weeks prior to first visit or who is controlling the body weight.
•4) BMI =35kg/m2
•5) Subject with diseases as follows: cardiovascular disease, diabetes mellitus, thyroid gland dysfunction, infectious diseases, renal diseases, hepatic diseases, etc.
•6) Subject who is predicted to use prohibited drugs or consumption of oriental medicine during the experimental period
•7) Subject with hypersensitivity to test materials
•8) Consumption of dietary supplements that can affect cardiovascular function within 4 weeks prior to the first visit
•9) Participation in other human study within 12 weeks prior to the first visit
•10) Pregnant or lactating woman
•11) Any condition that the principal investigator believes may put the subjects at undue risk

发起方